Therapeutic effectiveness of Magnolin on cancers and other human complications

Therapeutic effectiveness of Magnolin on cancers and other human complications

Backgrounds: Lignan is ubiquitous within the plant kingdom and present in almost all plants, including Magnolia fargesii Cheng. and Magnolia fargesii. Lignan has been used for the treatment of human health complications, including allergic rhinitis. Magnolin is a lignan class phytochemical abundantl...

Full description

Bibliographic Details
Main Author:	Dinesh Kumar Patel
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Pharmacological Research - Modern Chinese Medicine
Subjects:	Magnolin Prostate cancer Ovarian cancer Lung cancer Breast cancer Hepatocellular carcinoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667142522001622

Similar Items

Anticancer Potentials of the Lignan Magnolin: A Systematic Review
by: Md. Shimul Bhuia, et al.
Published: (2023-04-01)

Magnolin Inhibits Paclitaxel-Induced Cold Allodynia and ERK1/2 Activation in Mice
by: Nari Kim, et al.
Published: (2023-06-01)

Magnolin alleviated DSS‐induced colitis by inhibiting ALOX5‐mediated ferroptosis
by: Ting Yao, et al.
Published: (2024-04-01)

AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
by: Michael T. Schweizer, et al.
Published: (2017-01-01)

Editorial: Molecular and multi-omic approaches in understanding cancer biology and anticancer therapies: current perspectives and new challenges
by: Basel A. Abdel-Wahab, et al.
Published: (2023-06-01)

Tetrahydrofurofuranoid Lignans, Eudesmin, Fargesin, Epimagnolin A, Magnolin, and Yangambin Inhibit UDP-Glucuronosyltransferase 1A1 and 1A3 Activities in Human Liver Microsomes
by: Ria Park, et al.
Published: (2021-02-01)

Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022
by: Husain Yar Khan, et al.
Published: (2023-04-01)

Recent Discoveries on the Involvement of Krüppel-Like Factor 4 in the Most Common Cancer Types
by: Agnieszka Taracha-Wisniewska, et al.
Published: (2020-11-01)

Mechanisms of Taxane Resistance
by: Sara M. Maloney, et al.
Published: (2020-11-01)

Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers
by: Maritza P. Garrido, et al.
Published: (2023-03-01)

Evidence Update on the Relationship between Diet and the Most Common Cancers from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: A Systematic Review
by: Esther Ubago-Guisado, et al.
Published: (2021-10-01)

The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers
by: Lucas F. Freitas, et al.
Published: (2021-09-01)

Role of estrogen receptors in cancer: a special emphasis on the therapeutic potential of estrogen receptor β
by: Emdormi Rymbai, et al.
Published: (2022-09-01)

A Narrative Review of the Use of Artificial Intelligence in Breast, Lung, and Prostate Cancer
by: Kishan Patel, et al.
Published: (2023-10-01)

Estrogen Receptor Signaling in Cancer
by: Simon P. Langdon
Published: (2020-09-01)

The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study
by: Nicola L. Barclay, et al.
Published: (2024-03-01)

The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer
by: Tomislav Pejčić, et al.
Published: (2023-02-01)

The 15-year national trends of genital cancer incidence among Iranian men and women; 2005–2020
by: Gita Shafiee, et al.
Published: (2023-03-01)

Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives
by: Sicon Mitra, et al.
Published: (2022-01-01)

37-year incidence and mortality time trends of common cancer types by sex, age, and stage in the canton of Zurich
by: Miriam Wanner, et al.
Published: (2020-12-01)

Potential Diagnostic Value of Salivary Tumor Markers in Breast, Lung and Ovarian Cancer: A Preliminary Study
by: Lyudmila V. Bel’skaya, et al.
Published: (2023-06-01)

Effects of Antioxidants in Human Cancers: Differential Effects on Non-Coding Intronic RNA Expression
by: Shreya Menon, et al.
Published: (2016-01-01)

Anti-Algics in the Therapeutic Response of Breast and Urological Cancers
by: Ana Catarina Matos, et al.
Published: (2023-12-01)

Report on the Effect of the Implementation of an Early Detection and Prevention of Cancer Program on Families at High Hereditary Risk—Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland
by: Tadeusz Kałużewski, et al.
Published: (2023-08-01)

Educational differences in healthcare use among survivors after breast, prostate, lung, and colon cancer – a SEQUEL cohort study
by: Anne Katrine Graudal Levinsen, et al.
Published: (2023-06-01)

Role of Pyroptosis in Gynecological Oncology and Its Therapeutic Regulation
by: Yi Huang, et al.
Published: (2022-07-01)

Society's attitudes and knowledge about cancer inheritance and its genetic diagnosis
by: Agnieszka Pająk, et al.
Published: (2021-09-01)

Role of myeloid-derived suppressor cells in hormone-dependent cancers
by: Siddhartha Mukherjee, et al.
Published: (2021-03-01)

Prognostic Cancer Gene Expression Signatures: Current Status and Challenges
by: Yuquan Qian, et al.
Published: (2021-03-01)

Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in <i>BRCA</i> and in Other Susceptibility Genes
by: Giovanna D’Elia, et al.
Published: (2022-09-01)

Sensor Technology for Opening New Pathways in Diagnosis and Therapeutics of Breast, Lung, Colorectal and Prostate Cancer
by: Saeed Roshani, et al.
Published: (2022-09-01)

Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers
by: Morteza Abyadeh, et al.
Published: (2020-11-01)

Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms
by: Alessandro Maugeri, et al.
Published: (2023-02-01)

Understanding the Mechanisms of Diet and Outcomes in Colon, Prostate, and Breast Cancer; Malignant Gliomas; and Cancer Patients on Immunotherapy
by: Shivtaj Mann, et al.
Published: (2020-07-01)

<i>BARD1</i> Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort
by: Paula Rofes, et al.
Published: (2021-01-01)

Choices for cancer prevention for women with a BRCA1 mutation? a personal view
by: Steven A. Narod
Published: (2023-11-01)

The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update
by: Noushin Lotfi, et al.
Published: (2023-02-01)

Primary multiple BRCA associated breast cancer and ovarian cancer (clinical case)
by: I. B. Kononenko, et al.
Published: (2020-07-01)

Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers
by: Yasmine Lounici, et al.
Published: (2022-09-01)

Cancer Associated PRDM9: Implications for Linking Genomic Instability and Meiotic Recombination
by: Paris Ladias, et al.
Published: (2023-11-01)